中文部分
1.嚴玉華、許碩芬、方世杰、孫緒媛, 總額支付制度下個別醫院醫療費用預測模型建立-以某教學醫院為例. 澄清醫護管理雜誌, 2009. 5(2): p. 15-21.2.譚家惠, 重大傷病住院病患醫療資源利用情形, 2004, 撰者.
3.羅紀琼、詹維玲, 醫院總額預算對費用單價與服務量的影響初探. 臺灣公共衛生雜誌, 2007: p. 261-269.
4.鄭靜明, 臺灣地區精神科憂鬱症醫療利用分析, 醫務管理研究所2006, 國立陽明大學: p. 103.
5.蔣語涵, 精神專科醫院與綜合科醫院精神科醫療資源利用與醫療品質之比較, 醫務管理學研究所碩士在職專班2011, 高雄醫學大學: p. 140.6.鄒音美, 精神分裂症醫療給付改善方案之評估-以中部某精神醫院為例, in 健康產業管理學系健康管理組在職專班, 亞洲大學: p. 54.
7.葉玲玲、藍忠孚、鄭若瑟, 台灣精神分裂症患者精神醫療利用與費用之分析探討. 臺灣公共衛生雜誌, 2003. 22(3): p. 194-203.8.葉玲玲, 台灣精神分裂症患者之健康照護需要與需求研究,公共衛生研究所2003, 國立陽明大學: p. 276.
9.葉玲玲, 嚴重精神病患罹病成本之研究,衛生福利研究所1995, 國立陽明大學: p. 98.
10.葉俊廷, 運用品質機能展開探討內部服務品質–以中部某精神專科醫院為例, in 工業工程與管理研究所碩士班2009, 雲林科技大學: p. 88.11.黃國哲、陳怡樺、張蕙芝、張維容、溫信財、邱瓊萱, 總額支付制度實施後醫院的適應策略分析. 臺灣公共衛生雜誌, 2007. 26(4): p. 283-291.
12.黃品嘉, 全民健保支付制度演進與醫院生產效率. 2006.
13.陳素珊, 醫院總額支付制度實施前後對固定醫院就醫病患醫療利用比較之研究. 亞洲大學健康管理研究所學位論文, 2006.
14.陳素宜, 精神分裂症醫療給付改善方案實施成效評估-以全民健康保險資料庫為例,醫務管理學系碩士在職專班2012, 中國醫藥大學: p. 66.15.陳明鐘, 私立精神專科醫院住院病患家屬滿意度之探討─以精神分裂症患者為例, 醫療機構管理研究所2006, 臺灣大學: p. 182.
16.陳大申, 臺灣地區精神疾病醫療利用分析, 醫務管理學研究所2003, 長庚大學: p. 118.
17.郭建成、崔秀倩、沈淑華、林麗娟、唐心北、張達人, 精神科醫院急性病房自動出院之預測因子. 臺灣精神醫學, 2005. 19(2): p. 128-136.18.許碩芬, 楊雅玲,陳和全, 社會困境?-全民健保總額預算制下醫療提供者策略的均衡分析. 管理學報, 2007: p. 155-166.19.莊念慈、黃國哲、許怡欣、郭乃文、魏中仁, 醫院因應總額支付制度之策略方案及其相關因素探討. 臺灣公共衛生雜誌, 2004: p. 150-158.20.唐心北, 精神分裂症患者自動出院預測因子之探討-以一所公立精神專科教學醫院為例,公共衛生學研究所碩士在職專班2004, 高雄醫學大學: p. 101.21.胡敦富, 精神專科醫療院所人力投入對服務績效影響之研究 -以台灣地區七家公立精神專科醫院為例- 高階公共政策碩士班2007, 國立中山大學: p. 106.22.金家玉, 市場競爭對醫院產出表現的影響. 未出版碩士論文, 國立陽明大學, 2003.23.邱献章, 全民健保個別醫院總額支付制度對精神科醫師處方行為影響之研究,高階公共管理組 2007, 臺灣大學: p. 52.
24.林慧修, 部分負擔對不同種類醫療服務之影響分析,醫務管理研究所2002, 國立陽明大學: p. 171.
25.林偕益, 精神分裂症患者醫療資源使用之影響因子探討,公共衛生學研究所碩士在職專班2004, 高雄醫學大學: p. 101.26.沈詩佩, 醫院總額支付制度實施前後對精神分裂症患者醫療利用比較之研究,醫務管理研究所2011, 國立中山大學: p. 116.
27.李靜玟, 市場競爭及其他因素對精神醫療機構產出表現之影響, 醫務管理研究所2004, 國立陽明大學.
28.李名蟬, 精神專科教學醫院住院病人自傷趨勢及導致傷害與否之影響因素研究,健康產業管理學系健康管理組碩士在職專班2012, 亞洲大學: p. 48.29.吳肖琪、吳義勇、朱慧凡、林嘉彥、李鐘祥、張錦文、藍忠孚, 我國醫院醫療品質指標使用之情形. 醫療品質, 2002. 2(2): p. 1-14.30.余珮琦, 住院醫療服務市場之供給誘發需求現象探討, 2003, National Taiwan University.
31.江東亮, 臺灣醫療保健支出之趨勢分析. 2002.
32.朱菊新、李玉春、黃昱瞳、葉玲玲、黃光華, 醫院卓越計畫對精神分裂症門診病患換藥行爲之影響. 醫務管理期刊, 2007. 8(4): p. 301-316.33. 行政院衛生署中央健康保險局: 全民健康保險簡介(2012-2013版). http://www.nhi.gov.tw/resource/Webdata/20782_1_2012-2013全民健康保險簡介.pdf
34. 行政院衛生署中央健康保險局:全民健康保險精神分裂症醫療給付改善方
案.
http://www.nhi.gov.tw/Resource/webdata/19255_2_公告-精神分裂症改
善方案.pdf
35. 行政院主計總處:國情統計通報(2012年10月引用) http://www.dgbas.gov.tw/lp.asp?CtNode=1481&CtUnit=690&BaseDSD=7&xq_xCat=09
36. 王俊凱、周元華, 精神分裂症, 2005, 臨床醫學.37. 李明濱, 整合性精神醫療體系規劃研究第一年-病患分類、治療指引及品
質監控系統,行政院衛生署中央健保局八十八年下半年及八十九年上半年
度委託研究計劃 2000.
38. 劉蓉台, 精障個案社區整合照顧模式. 護理雜誌, 2007. 54(5): p.11-17.
39. 宋鴻生, 精神醫療機構對不同支付制度之態度與醫療服務變化相關因素
探討, 2003, National Taiwan University Department of Health Care
Organization Administration.
40. 行政院衛生署:99年度醫療服務量
http://www.doh.gov.tw/CHT2006/DM/DM2_2.aspx?now_fod_list_no=
11924&class_no=440&level_no=3
41. 楊長興, 賴芳足,長庚醫學暨工程學院醫務管理學系, 全民健保實
施對於民眾醫療利用率影響之初期評估. 1996: 中央健康保險局.
42. 黃品嘉, 全民健保支付制度演進與醫院生產效率. 2006.
英文部分
1. Baca-garcia, E., Perez-rodriguez, M.M.,Basurte-villamor, I.,Quintero-gutierrez, F. J.,Sevilla-vicente, J.,Martinez-vigo, M.,Artes-rodriguez, .,Fernandez D.M.A.,Jimenez-arriero, M. A.,Gonzalez D. R.J., Patterns ofmental health service utilization in a general hospital and outpatient mental health facilities. European Archives of Psychiatry and Clinical Neuroscience, 2008. 258(2): p. 17-23.
2.Barro, J.R., Huckman, R.S. and Kessler, D.P. The effects of cardiac specialty hospitals on the cost and quality of medical care. Journal of Health Economics, 2006. 25(4): p. 702-721.
3.Bloom, J.R.,Wang, H.,Kang, S.H.,Wallace, N.T.,Hyun, J.K.,Hu, T., Capitation of Public Mental Health Services in Colorado: A Five-Year Follow-Up of System-Level Effects. Psychiatric Services, 2011. 62(2): p. 179-85.
4. Brown, S.,Barraclough, B.,Inskip, H., Causes of the excess mortality of schizophrenia. The British Journal of Psychiatry, 2000. 177(3): p. 212-217.
5. Cahoon, E.K., McGinty, E.E.,Ford, D.E.,Daumit, G.L., Schizophrenia and potentially preventable hospitalizations in the United States: a retrospective cross-sectional study. BMC Psychiatry, 2013. 13(1): p. 37.
6. Chien, I.C., Chou, Y.J.,Lin, C.H.,Bih, S.H.,Chou, P.,Chang,
H.J.,Prevalence and incidence of schizophrenia among national health
insurance enrollees in Taiwan, 1996–2001. Psychiatry and Clinical
Neurosciences, 2004. 58(6): p. 611-618.
7. Chien, I.C., Kuo, C.C.,, The Prevalence and Incidence of Treated Major Depressive Disorder Among National Health Insurance Enrollees in Taiwan, 1996 to 2003. Canadian Journal of Psychiatry, 2007. 52(1): p. 28-36.
8. Chisholm, D., Gureje, O.,Saldivia, S.,Calderón, M.V.,Wickremasinghe, R.,Mendis, N.,Ayuso-Mateos, J.L.,Saxena, S., Schizophrenia treatment in the developing world: an interregional and multinational cost-effectiveness analysis. World Health Organization. Bulletin of the World Health Organization, 2008. 86(7): p. 542-51.
9. Davies, L.M. and Drummond, M.F.,Economics and schizophrenia: The real cost. British Journal of Psychiatry, 1994.
10.De Hert,M.,Thys, E.,Boydens, J.,Gilis, P., Health care expenditure on schizophrenia patients in Belgium. Schizophrenia Bulletin, 1998. 24(4): p. 519-27.
11.Dickey, B., Assessing cost and utilization in managed mental health care in the United States. Health policy, 1997. 41: p. S163-S174.
12.Etter, J.-F. and Perneger, T.V., Health care expenditures after introduction of a gatekeeper and a global budget in a Swiss health insurance plan. Journal of epidemiology and community health, 1998. 52(6): p. 370-376.
13.Figueroa, R., Harman, J. and Engberg, J., Use of claims data to examine the impact of length of inpatient psychiatric stay on readmission rate. Psychiatric Services, 2004. 55(5): p. 560-565.
14.Fortney, J.C.P.,Xu, S. and Dong, F., Community-Level Correlates of Hospitalizations for Persons With Schizophrenia. Psychiatric Services, 2009. 60(6): p. 772-8.
15.Gilligan, J., The Last Mental Hospital. Psychiatric Quarterly, 2001. 72(1): p. 45-61.
16.Goldman, W.,McCulloch, J.and Sturm, R., Costs and use of mental health services before and after managed care. Health Affairs, 1998. 17(2): p. 40-52.
17.Goldner, E.M., Hsu, L.,Waraich, P.,Somers, J. M., Prevalence and incidence studies of schizophrenic disorders: a systematic review of the literature. Canadian Journal of Psychiatry, 2002. 47(9): p. 833-43.
18.Johnstone, P. and Zolese, G., Systematic review of the effectiveness of planned short hospital stays for mental health care. British Medical Journal, 1999. 318(7195): p. 1387-90.
19.Kirkbride, J.B.,Errazuriz, A.,Croudace, T.J.Morgan, C.,Jackson, D.,Boydell, J.,Murray, R.M.,Jones, P.B., Incidence of Schizophrenia and Other Psychoses in England, 1950-2009: A Systematic Review and Meta-Analyses. PLoS One, 2012. 7(3).
20.Kaplan H.I., Sadock B.J., Synopsis of Psychiatry, 9th edn. Williams
Wilkins, New York, 2003.
21.Kapur, K.,Young, A.S.,Murata, D.,Greer S.,Koegel, P., The economic impact of capitated care for high utilizers of public mental health services: the Los Angeles PARTNERS program experience. The journal of behavioral health services & research, 1999. 26(4): p. 416-429.
22.Kumar, K., Subramanian, R. and Yauger, C., Examining the market orientation-performance relationship: a context-specific study. Journal of management, 1998. 24(2): p. 201-233.
23.Leslie, D.L. and Rosenheck, R., Shifting to outpatient care? Mental health care use and cost under private insurance. The American Journal of Psychiatry, 1999. 156(8): p. 1250-7.
24.Mai, Q.,Holman, C. D.,Sanfilippo, F.,Emery, J., The impact of mental illness on potentially preventable hospitalisations: a population-based cohort study. BMC psychiatry, 2011. 11(1): p. 163.
25.Martin, B.C. and Miller, L.S., Expenditures for treating schizophrenia: A population-based study of Georgia Medicaid recipients. Schizophrenia Bulletin, 1998. 24(3): p. 479-88.
26.Mavranezouli, I., A Review and Critique of Studies Reporting Utility Values for Schizophrenia-Related Health States. PharmacoEconomics, 2010. 28(12): p. 1109-21.
27.McFarland, B.H. and Collins, J.C., Medicaid Cutbacks and State Psychiatric Hospitalization of Patients With Schizophrenia. Psychiatric Services, 2011. 62(8): p. 871-7.
28.McGrath, J., Saha, S.,Chant, D.,Welham, J., Schizophrenia: a concise overview of incidence, prevalence, and mortality. Epidemiologic Reviews, 2008. 30(1): p. 67-76.
29.Mojtabai, R., Fochtmann, L.,Chang S.W.,Kotov, R.,Craig, T.J., Bromet, E., Unmet Need for Mental Health Care in Schizophrenia: An Overview of Literature and New Data From a First-Admission Study. Schizophrenia Bulletin, 2009. 35(4): p. 679-95.
30.Moreno-Küstner, B.,Mayoral, F.,Rivas, F.,Angona, P.,Requena, J.,García-Herrera, J.M.,Navas, D.,Moreno, P.,Serrano-Blanco, A.,Bellón, J. A., Factors associated with use of community mental health services by schizophrenia patients using multilevel analysis. BMC Health Services Research, 2011. 11(1): p. 257-257.
31.Mueser, K.T. and McGurk, S.R., Schizophrenia. The Lancet, 2004. 363(9426): p. 2063-72.
32.Nallamothu, B.K., Rogers, M.A.,Chernew, M.E.,Krumholz, H.M.,Eagle,
K.A.,Birkmeyer, J. D., Opening of specialty cardiac hospitals and use of coronary revascularization in Medicare beneficiaries. JAMA: the journal of the American Medical Association, 2007. 297(9): p. 962-968.
33.Palmer, B.A., Pankratz, V.S. and Bostwick, J.M., The Lifetime Risk of Suicide in Schizophrenia: A Reexamination. Archives of General Psychiatry, 2005. 62(3): p. 247-53.
34.Rice, D.P., The economic impact of schizophrenia. The Journal of Clinical Psychiatry, 1999. 60: p. 4-6; discussion 28-30.
35.Regier, D. A.,Narrow, W. E.,Rae, D. S.,Manderscheid, R. W.,Locke, B. Z.,Goodwin, F. K., The de facto US mental and addictive disorders service system. Epidemiologic catchment area prospective 1-year prevalence rates of disorders and services. Arch Gen Psychiatry, 1993. 50(2): p. 85-94.
36.Rothbard, A.B.,Schinnar, A.P.,Hadley, T.P.,Foley, K.A.,Kuno, E., Cost comparison of state hospital and community-based care for seriously mentally ill adults. The American Journal of Psychiatry, 1998. 155(4): p. 523-9.
37.Rothbard, A.B., Kuno, E.,Schinnar, A.P.,Hadley, T.R.,Turk, R., Service utilization and cost of community care for discharged state hospital patients: A 3-year follow-up study. The American Journal of Psychiatry, 1999. 156(6): p. 920-7.
38.Rothbard, A.B., Kuno, E.,Hadley, T.R.,Dogin, J., Psychiatric Service Utilization and Cost for Persons With Schizophrenia in a Medicaid Managed Care Program. The Journal of Behavioral Health Services & Research, 2004. 31(1): p. 1-12.
39.Saha, S., Chant, D.,Welham, J.,McGrath, J., A Systematic Review of the Prevalence of Schizophrenia. PLoS Medicine, 2005. 2(5): p. e141.
40.Saha S, C.D.M.J., A systematic review of mortality in schizophrenia: Is the differential mortality gap worsening over time? Archives of General Psychiatry, 2007. 64(10): p. 1123-1131.
41.Salokangas, R.K.R. and Saarinen, S., Deinstitutionalization and schizophrenia in Finland: I. Discharged patients and their care. Schizophrenia Bulletin, 1998. 24(3): p. 457-67.
42.Sarlon, E., Heider, D.,Millier, A.,Azorin, J.M.,König, H.H.,Hansen, K.,Angermeyer, M.C.,Aballéa, S.,Toumi, M., A prospective study of health care resource utilisation and selected costs of schizophrenia in France. BMC Health Services Research, 2012. 12(1): p. 269-76.
43.Saxena, S., Sharan, P., Garrido, M.,Saraceno, B., World Health Organization''s mental health atlas 2005: implications for policy development. World Psychiatry, 2006. 5(3): p. 179.
44.Soumerai, S.B.,McLaughlin, T.J.,Ross-Degnan, D.,Casteris, C.S.,Bollini, P., Effects of limiting Medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia. The New England Journal of Medicine, 1994. 331(10): p. 650-655.
45. Sun, S.X., Liu, G.G.Christensen, D.B.,Fu, A.Z., Review and analysis of hospitalization costs associated with antipsychotic nonadherence in the treatment of schizophrenia in the United States. Current Medical Research and Opinion, 2007. 23(10): p. 2305-12.
46.van Os, J. and Kapur, S., Schizophrenia. The Lancet, 2009. 374(9690): p. 635-45.
47.Wallace, C.,Mullen, P.E. and Burgess, P. , Criminal Offending in Schizophrenia Over a 25-Year Period Marked by Deinstitutionalization and Increasing Prevalence of Comorbid Substance Use Disorders. The American Journal of Psychiatry, 2004. 161(4): p. 716-27.
48.Wu, Eric Q,Shi, L.,Birnbaum, H.,Hudson, T.,Kessler, R.; Annual prevalence of diagnosed schizophrenia in the USA: a claims data analysis approach. Psychological Medicine, 2006. 36(11): p. 1535-1540.